Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study.

Anliker-Ort, Marion; Rodieux, Frédérique; Ziesenitz, Victoria C; Atkinson, Andrew; Bielicki, Julia A; Erb, Thomas O; Gürtler, Nicolas; Holland-Cunz, Stefan; Duthaler, Urs; Rudin, Deborah; Haschke, Manuel; van den Anker, John; Pfister, Marc; Gotta, Verena (2024). Pharmacokinetics-Based Pediatric Dose Evaluation and Optimization Using Saliva - A Case Study. Journal of clinical pharmacology, 64(7), pp. 810-819. Wiley 10.1002/jcph.2428

Preview

Text The_Journal_of_Clinical_Pharma_-_2024_-_Anliker_Ort_-_Pharmacokinetics_Based_Pediatric_Dose_Evaluation_and_Optimization.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial (CC-BY-NC). Download (907kB) | Preview

Understanding pharmacokinetics (PK) in children is a prerequisite to determine optimal pediatric dosing. As plasma sampling in children is challenging, alternative PK sampling strategies are needed. In this case study we evaluated the suitability of saliva as alternative PK matrix to simplify studies in infants, investigating metamizole, an analgesic used off-label in infants. Six plasma and 6 saliva PK sample collections were scheduled after a single intravenous dose of 10 mg/kg metamizole. Plasma/saliva pharmacometric (PMX) modeling of the active metabolites 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA) was performed. Various reduced plasma sampling scenarios were evaluated by PMX simulations. Saliva and plasma samples from 25 children were included (age range, 5-70 months; weight range, 8.7-24.8 kg). Distribution of metamizole metabolites between plasma and saliva was without delay. Estimated mean (individual range) saliva/plasma fractions of 4-MAA and 4-AA were 0.32 (0.05-0.57) and 0.57 (0.25-0.70), respectively. Residual variability of 4-MAA (4-AA) in saliva was 47% (28%) versus 17% (11%) in plasma. A simplified sampling scenario with up to 6 saliva samples combined with 1 plasma sample was associated with similar PK parameter estimates as the full plasma sampling scenario. This case study with metamizole shows increased PK variability in saliva compared to plasma, compromising its suitability as single matrix for PK studies in infants. Nonetheless, rich saliva sampling can reduce the number of plasma samples required for PK characterization, thereby facilitating the conduct of PK studies to optimize dosing in pediatric patients.

Interest & Impact

Downloads

17 since deposited on 27 Mar 2024
17 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item